abstract |
JPEG2022505272000059.jpg 2294 The present disclosure provides topoisomerase II inhibitory compounds having the structures of Formulas II and III, and compositions thereof for use in the treatment of cancer. In particular, the topoisomerase II inhibitory compound may be a catalytic inhibitor of topoisomerase II. |